Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000874716-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-16 | 2024-02-14 | IDXX | Hunt Nimrata | EVP | A - Grant | $0.00 | +208 | 11.9K | +2% | $0 |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Hunt Nimrata | EVP | M - OptEx | $0.00 | +664 | 11.2K | +6% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Hunt Nimrata | EVP | F - Tax | $560.56 | -263 | 11.7K | -2% | -$147.4K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Hunt Nimrata | EVP | M - OptEx | $0.00 | -872 | 0 | -100% | $0 |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Hunt Nimrata | EVP | A - Grant | $0.00 | +6,789 | 5,407 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | A | A | 208 | $0.00 | 11,939.23 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | M | A | 204 | $0.00 | 11,731.23 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-14 | M | A | 161 | $0.00 | 11,527.23 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-14 | M | A | 173 | $0.00 | 11,366.23 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-14 | M | A | 126 | $0.00 | 11,193.23 | D | — | — | (F1) Includes a total of 51.95 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023. |
| 6 | Common | Common Stock | 2024-02-14 | F | D | 263 | $560.56 | 11,676.23 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 208 | $0.00 | 621 | D | — · — to — | 208 Common Stock | (F9) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 204 | $0.00 | 408 | D | — · — to — | 204 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 9 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 161 | $0.00 | 160 | D | — · — to — | 161 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 10 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 126 | $0.00 | 0 | D | — · — to — | 126 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020. |
| 11 | Derivative | Restricted Stock Unit | 2024-02-14 | A | A | 1,204 | $0.00 | 1,204 | D | — · — to — | 1,204 Common Stock | (F4) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. |
| 12 | Derivative | Incentive Stock Option (right-to-buy) | 2024-02-14 | A | A | 178 | $0.00 | 178 | D | $560.56 · — to 2034-02-13 | 178 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. |
| 13 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-02-14 | A | A | 5,407 | $0.00 | 5,407 | D | $560.56 · — to 2034-02-14 | 5,407 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. |
| 14 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 173 | $0.00 | 0 | D | — · — to — | 173 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021. |